Are Medical Stocks Lagging DURECT (DRRX) This Year?
H.C. Wainwright Maintains Durect(DRRX.US) With Hold Rating
Northland Securities Maintains Durect(DRRX.US) With Buy Rating, Maintains Target Price $8.5
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)
12 Health Care Stocks Moving In Tuesday's After-Market Session
Express News | Hearing Oppenheimer Reiterates Outperform And $5 PT On DURECT
Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon
DURECT Gets FDA Breakthrough Therapy Status for Larsucosterol
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | DURECT Corp -DURECT Plans to Confirm Efficacy and Safety of Larsucosterol in a Registrational Phase 3 Clinical Trial
Express News | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
Express News | HC Wainwright & Co. Reiterates Neutral on Durect
Durect Analyst Ratings
Durect | 10-Q: Quarterly report
Express News | DURECT Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Revenue Results
Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says
Cutera, Inotiv, Treace Medical Concepts Among Healthcare Movers
Durect (DRRX) Gets a Buy From Oppenheimer
Durect (DRRX) Receives a Hold From H.C. Wainwright
Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...